Loading clinical trials...
Loading clinical trials...
A single centre, double-blind, placebo-controlled study to evaluate the effect of the consumption of Bacillus coagulans at a daily dose of 1 x 10⁹ CFU on bowel habits, intestinal microbiota and gastro...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Kerry Group P.L.C
Collaborators
NCT07545772 · Irritable Bowel Syndrome, Constipation
NCT07578103 · Body Composition Changes, Body Weight Change, and more
NCT05588323 · Opioid-Induced Constipation (OIC)
NCT07550023 · Short Chain Fatty Acids Concentration in Stools, Gut Microbiota Diversity and Composition, and more
NCT06347770 · Microbiota, Postoperative Recovery
Beijing Hospital
Beijing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions